Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors.
Not Applicable
- Conditions
- Gynecologic cancer
- Registration Number
- JPRN-UMIN000013951
- Lead Sponsor
- Department of Obstetrics and Gynecology, Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
history of gemecitabine or docetaxel
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PFS, Response rate, OS, AEs, QOL, molecular profiling
- Secondary Outcome Measures
Name Time Method